Non-paired comparison of endoscopic ultrasound-guided and transjugular liver approaches using different needles : can firm conclusions be made?
Source
Clinical gastroenterology and hepatology - ISSN 1542-3565-24:10 (2026) p. 2890-2891
EASL-AASLD Delphi consensus statement on surrogate endpoints and real-world evidence in primary biliary cholangitis
Source
Journal of hepatology - ISSN 0168-8278-85:3 (2026) p. 583-602
Non-invasive assessment and therapeutic targeting in metabolic dysfunction-associated steatohepatitis (MASH) : overcoming the dissonance between drug development and precision medicine
Source
Drugs - ISSN 0012-6667-86:10 (2026) p. 1619-1643
Efficacy and safety of zalfermin co-administered with semaglutide in participants with fibrosis and cirrhosis due to metabolic dysfunction-associated steatohepatitis : a phase 2, dose-ranging, double-blind, randomised controlled trial
Source
Lancet gastroenterology & hepatology - ISSN 2468-1253-11:9 (2026) p. 797-811
Hepatology : emerging paradigms in MASLD, viral hepatitis, cholestatic liver disease, portal hypertension and hepatocellular carcinoma
Source
Liver international - ISSN 1478-3223-46:9 (2026) p.